Clinical testing in patient care for Yt antigens follows published minimum quality and operational requirements,[2] similar to red cell genotyping for any of the other recognized blood group systems. Molecular analysis can identify gene variants (alleles) that may affect Yt antigens expression on the red cell membrane.